[1]
|
Ondari, E., Calvino-Sanles, E., First, N.J. and Gestal, M.C. (2021) Eosinophils and Bacteria, the Beginning of a Story. International Journal of Molecular Sciences, 22, Article 8004. https://doi.org/10.3390/ijms22158004
|
[2]
|
Tashkin, D.P. and Wechsler, M.E. (2018) Role of Eosinophils in Airway Inflammation of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 13, 335-349. https://doi.org/10.2147/copd.s152291
|
[3]
|
Brightling, C. and Greening, N. (2019) Airway Inflammation in COPD: Progress to Precision Medicine. European Respiratory Journal, 54, Article 1900651. https://doi.org/10.1183/13993003.00651-2019
|
[4]
|
Chan, M.C., Yeung, Y.C., Yu, E.L.M. and Yu, W.C. (2020) Blood Eosinophil and Risk of Exacerbation in Chronic Obstructive Pulmonary Disease Patients: A Retrospective Cohort Analysis. International Journal of Chronic Obstructive Pulmonary Disease, 15, 2869-2877. https://doi.org/10.2147/copd.s268018
|
[5]
|
Vedel-Krogh, S., Nielsen, S.F., Lange, P., Vestbo, J. and Nordestgaard, B.G. (2016) Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study. American Journal of Respiratory and Critical Care Medicine, 193, 965-974. https://doi.org/10.1164/rccm.201509-1869oc
|
[6]
|
Couillard, S., Larivée, P., Courteau, J. and Vanasse, A. (2017) Eosinophils in COPD Exacerbations Are Associated with Increased Readmissions. Chest, 151, 366-373. https://doi.org/10.1016/j.chest.2016.10.003
|
[7]
|
Prudente, R., Ferrari, R., Mesquita, C.B., Machado, L.H., Franco, E.A., Godoy, I., et al. (2021) Peripheral Blood Eosinophils and Nine Years Mortality in COPD Patients. International Journal of Chronic Obstructive Pulmonary Disease, 16, 979-985. https://doi.org/10.2147/copd.s265275
|
[8]
|
Ho, J., He, W., Chan, M.T.V., Tse, G., Liu, T., Wong, S.H., et al. (2017) Eosinophilia and Clinical Outcome of Chronic Obstructive Pulmonary Disease: A Meta-Analysis. Scientific Reports, 7, Article No. 13451. https://doi.org/10.1038/s41598-017-13745-x
|
[9]
|
Paliogiannis, P., Fois, A.G., Sotgia, S., Mangoni, A.A., Zinellu, E., Pirina, P., et al. (2018) The Neutrophil-to-Lymphocyte Ratio as a Marker of Chronic Obstructive Pulmonary Disease and Its Exacerbations: A Systematic Review and Meta-Analysis. European Journal of Clinical Investigation, 48, e12984. https://doi.org/10.1111/eci.12984
|
[10]
|
El-Gazzar, A.G., Kamel, M.H., Elbahnasy, O.K.M. and El-Naggar, M.E. (2019) Prognostic Value of Platelet and Neutrophil to Lymphocyte Ratio in COPD Patients. Expert Review of Respiratory Medicine, 14, 111-116. https://doi.org/10.1080/17476348.2019.1675517
|
[11]
|
Luo, Z., Zhang, W., Chen, L. and Xu, N. (2021) Prognostic Value of Neutrophil: Lymphocyte and Platelet: Lymphocyte Ratios for 28-Day Mortality of Patients with AECOPD. International Journal of General Medicine, 14, 2839-2848. https://doi.org/10.2147/ijgm.s312045
|
[12]
|
Alupo, P., Katagira, W., Mukunya, D., Okimat, P., Tejwani, V., Kayongo, A., et al. (2024) The Neutrophil-to-Lymphocyte Ratio as a Predictor of Acute Exacerbations among Patients with COPD in Uganda. Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, 11, 187-195. https://doi.org/10.15326/jcopdf.2023.0443
|
[13]
|
Feng, X., Xiao, H., Duan, Y., Li, Q. and Ou, X. (2023) Prognostic Value of Neutrophil to Lymphocyte Ratio for Predicting 90-Day Poor Outcomes in Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 18, 1219-1230. https://doi.org/10.2147/copd.s399671
|
[14]
|
Kose Kabil, N., Karakurt, Z., Gundogus, B., Gungor, A., Akyuz, K. and Turker, H. (2023) Peripheral Blood Eosinophilia and Neutrophil Lymphocyte Ratio in the Choice of Antibiotic And/or Steroid in Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Thoracic Research and Practice, 24, 220-227. https://doi.org/10.5152/thoracrespract.2023.21281
|
[15]
|
Murat, S.N., Yarlioglues, M., Celik, I.E., Kurtul, A., Duran, M., Kilic, A., et al. (2016) The Relationship between Lymphocyte-to-Monocyte Ratio and Bare-Metal Stent In-Stent Restenosis in Patients with Stable Coronary Artery Disease. Clinical and Applied Thrombosis/Hemostasis, 23, 235-240. https://doi.org/10.1177/1076029615627340
|
[16]
|
Han, L., Jia, Y., Song, Q., Wang, J., Wang, N. and Cheng, Y. (2015) Prognostic Significance of Preoperative Lymphocyte-Monocyte Ratio in Patients with Resectable Esophageal Squamous Cell Carcinoma. Asian Pacific Journal of Cancer Prevention, 16, 2245-2250. https://doi.org/10.7314/apjcp.2015.16.6.2245
|
[17]
|
Barnes, P.J. (2019) Inflammatory Endotypes in COPD. Allergy, 74, 1249-1256. https://doi.org/10.1111/all.13760
|
[18]
|
Kor, C., Li, Y., Lin, P., Lin, S., Wang, B. and Lin, C. (2022) Explainable Machine Learning Model for Predicting First-Time Acute Exacerbation in Patients with Chronic Obstructive Pulmonary Disease. Journal of Personalized Medicine, 12, Article 228. https://doi.org/10.3390/jpm12020228
|
[19]
|
Lim, S.C., Ju, J.Y., Chi, S.Y., Ban, H.J., Kwon, Y.S., Oh, I.J., et al. (2011) Apoptosis of T Lymphocytes Isolated from Peripheral Blood of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Yonsei Medical Journal, 52, Article 581. https://doi.org/10.3349/ymj.2011.52.4.581
|
[20]
|
Long, J., Ouyang, Y., Duan, H., Xiang, Z., Ma, H., Ju, M., et al. (2020) Multiple Factor Analysis of Depression and/or Anxiety in Patients with Acute Exacerbation Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 15, 1449-1464. https://doi.org/10.2147/copd.s245842
|
[21]
|
Eraslan Doganay, G. and Cirik, M.O. (2022) Are Neutrophil-Lymphocyte, Platelet-Lymphocyte, and Monocyte-Lymphocyte Ratios Prognostic Indicators in Patients with Chronic Obstructive Pulmonary Disease in Intensive Care Units? Cureus, 14, e23499. https://doi.org/10.7759/cureus.23499
|
[22]
|
Rayes, J., Bourne, J.H., Brill, A. and Watson, S.P. (2020) The Dual Role of Platelet-Innate Immune Cell Interactions in Thrombo-Inflammation. Research and Practice in Thrombosis and Haemostasis, 4, 23-35. https://doi.org/10.1002/rth2.12266
|
[23]
|
Muñoz-Esquerre, M., Ferreiro, J.L., Huertas, D., Marcano, A.L., López-Sánchez, M., Roura, G., et al. (2017) Impact of Acute Exacerbations on Platelet Reactivity in Chronic Obstructive Pulmonary Disease Patients. International Journal of Chronic Obstructive Pulmonary Disease, 13, 141-148. https://doi.org/10.2147/copd.s152660
|
[24]
|
Robert, L. and Labat-Robert, J. (2017) Platelets, Micro-Particles and Elastase. A Review with Extrapolation to the Mechanism of Generation and Bio-Pathology of Platelet Fragments. Pathology & Oncology Research, 23, 455-458. https://doi.org/10.1007/s12253-017-0199-1
|
[25]
|
Zinellu, A., Paliogiannis, P., Sotgiu, E., Mellino, S., Fois, A.G., Carru, C., et al. (2021) Platelet Count and Platelet Indices in Patients with Stable and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. COPD: Journal of Chronic Obstructive Pulmonary Disease, 18, 231-245. https://doi.org/10.1080/15412555.2021.1898578
|
[26]
|
Song, W., Wang, Y., Tian, F., Ge, L., Shang, X., Zeng, Q., et al. (2021) Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Disease Markers, 2021, Article 8879401. https://doi.org/10.1155/2021/8879401
|
[27]
|
Ergan, B., Şahin, A.A. and Topeli, A. (2016) Serum Procalcitonin as a Biomarker for the Prediction of Bacterial Exacerbation and Mortality in Severe COPD Exacerbations Requiring Mechanical Ventilation. Respiration, 91, 316-324. https://doi.org/10.1159/000445440
|
[28]
|
Zhang, Y. and Zhou, L. (2014) Diagnostic Value of C-Reactive Protein and Procalcitonin for Bacterial Infection in Acute Exacer-Bations of Chronic Obstructive Pulmonary Disease. Journal of Central South University (Medical Science), 39, 939-943.
|
[29]
|
Soler, N., Esperatti, M., Ewig, S., Huerta, A., Agustí, C. and Torres, A. (2012) Sputum Purulence-Guided Antibiotic Use in Hospitalised Patients with Exacerbations of COPD. European Respiratory Journal, 40, 1344-1353. https://doi.org/10.1183/09031936.00150211
|
[30]
|
Gao, D., Chen, X., Wu, H., Wei, H. and Wu, J. (2017) The Levels of Serum Pro-Calcitonin and High-Sensitivity C-Reactive Protein in the Early Diagnosis of Chronic Obstructive Pulmonary Disease during Acute Exacerbation. Experimental and Therapeutic Medicine, 14, 193-198. https://doi.org/10.3892/etm.2017.4496
|
[31]
|
Daniels, J.M.A., Schoorl, M., Snijders, D., Knol, D.L., Lutter, R., Jansen, H.M., et al. (2010) Procalcitonin vs C-Reactive Protein as Predictive Markers of Response to Antibiotic Therapy in Acute Exacerbations of COPD. Chest, 138, 1108-1115. https://doi.org/10.1378/chest.09-2927
|
[32]
|
Chen, K., Pleasants, K.A., Pleasants, R.A., Beiko, T., Washburn, R.G., Yu, Z., et al. (2020) Procalcitonin for Antibiotic Prescription in Chronic Obstructive Pulmonary Disease Exacerbations: Systematic Review, Meta-Analysis, and Clinical Perspective. Pulmonary Therapy, 6, 201-214. https://doi.org/10.1007/s41030-020-00123-8
|
[33]
|
Şahin, F., Koşar, A.F., Aslan, A.F., Yiğitbaş, B. and Uslu, B. (2019) Serum Biomarkers in Patients with Stable and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Comparative Study. Journal of Medical Biochemistry, 38, 503-511. https://doi.org/10.2478/jomb-2018-0050
|
[34]
|
Llor, C. and Miravitlles, M. (2020) C-Reactive Protein Point of Care Testing: The Answer to Antibiotic Prescribing in Ambulatory Patients with Exacerbations of Chronic Obstructive Pulmonary Disease? Expert Review of Respiratory Medicine, 15, 1-3. https://doi.org/10.1080/17476348.2020.1776611
|
[35]
|
Wang, J., Shang, H., Yang, X., Guo, S. and Cui, Z. (2019) Procalcitonin, C-Reactive Protein, PaCO2, and Noninvasive Mechanical Ventilation Failure in Chronic Obstructive Pulmonary Disease Exacerbation. Medicine, 98, e15171. https://doi.org/10.1097/md.0000000000015171
|
[36]
|
Fermont, J.M., Masconi, K.L., Jensen, M.T., Ferrari, R., Di Lorenzo, V.A.P., Marott, J.M., et al. (2019) Biomarkers and Clinical Outcomes in COPD: A Systematic Review and Meta-Analysis. Thorax, 74, 439-446. https://doi.org/10.1136/thoraxjnl-2018-211855
|
[37]
|
Sneh, A., Pawan, T., Randeep, G., Anant, M., Mani, K., Hadda, V., et al. (2019) Acute Phase Proteins as Predictors of Survival in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Mechanical Ventilation. COPD: Journal of Chronic Obstructive Pulmonary Disease, 17, 22-28. https://doi.org/10.1080/15412555.2019.1698019
|
[38]
|
Mohan, M., Parthasarathi, A., S K, C., Biligere Siddaiah, J. and Mahesh, P.A. (2021) Fibrinogen: A Feasible Biomarker in Identifying the Severity and Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Cureus, 13, e16864. https://doi.org/10.7759/cureus.16864
|
[39]
|
Kim, T.H., Oh, D.K., Oh, Y., Lee, S.W., Lee, S.D. and Lee, J.S. (2018) Fibrinogen as a Potential Biomarker for Clinical Phenotype in Patients with Chronic Obstructive Pulmonary Disease. Journal of Thoracic Disease, 10, 5260-5268. https://doi.org/10.21037/jtd.2018.08.52
|
[40]
|
Singh, D., Criner, G.J., Dransfield, M.T., Halpin, D.M.G., Han, M.K., Lange, P., et al. (2021) Informing the Pathway of COPD Treatment (IMPACT) Trial: Fibrinogen Levels Predict Risk of Moderate or Severe Exacerbations. Respiratory Research, 22, Article No. 130. https://doi.org/10.1186/s12931-021-01706-y
|
[41]
|
Kyriakopoulos, C., Gogali, A., Kostikas, K. and Konstantinidis, A. (2021) Hypercoagulable State in COPD—A Comprehensive Literature Review. Diagnostics, 11, Article 1447. https://doi.org/10.3390/diagnostics11081447
|
[42]
|
Zhang, M., Zhang, J., Zhang, Q., Yang, X., Shan, H., Ming, Z., et al. (2016) D-Dimer as a Potential Biomarker for the Progression of COPD. Clinica Chimica Acta, 455, 55-59. https://doi.org/10.1016/j.cca.2016.01.024
|
[43]
|
Husebø, G.R., Gabazza, E.C., D’Alessandro Gabazza, C., Yasuma, T., Toda, M., Aanerud, M., et al. (2020) Coagulation Markers as Predictors for Clinical Events in COPD. Respirology, 26, 342-351. https://doi.org/10.1111/resp.13971
|
[44]
|
Liu, B.H., Sun, M.X., Zhou, N., et al. (2016) Detection and Study of Plasma D-Dimer Change in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Journal of Biological Regulators and Homeostatic Agents, 30, 839-845.
|
[45]
|
Fruchter, O., Yigla, M. and Kramer, M.R. (2015) D-Dimer as a Prognostic Biomarker for Mortality in Chronic Obstructive Pulmonary Disease Exacerbation. The American Journal of the Medical Sciences, 349, 29-35. https://doi.org/10.1097/maj.0000000000000332
|
[46]
|
Hu, G., Wu, Y., Zhou, Y., Wu, Z., Wei, L., Li, Y., et al. (2016) Prognostic Role of D-Dimer for In-Hospital and 1-Year Mortality in Exacerbations of COPD. International Journal of Chronic Obstructive Pulmonary Disease, 11, 2729-2736. https://doi.org/10.2147/copd.s112882
|
[47]
|
McKinstry, K.K., Strutt, T.M., Buck, A., Curtis, J.D., Dibble, J.P., Huston, G., et al. (2009) IL-10 Deficiency Unleashes an Influenza-Specific Th17 Response and Enhances Survival against High-Dose Challenge. The Journal of Immunology, 182, 7353-7363. https://doi.org/10.4049/jimmunol.0900657
|
[48]
|
Ding, Q., Liu, G., Zeng, Y., Zhu, J., Liu, Z., Zhang, X., et al. (2017) Role of IL-17 in LPS-Induced Acute Lung Injury: An in vivo study. Oncotarget, 8, 93704-93711. https://doi.org/10.18632/oncotarget.21474
|
[49]
|
Jiang, S., Shan, F., Zhang, Y., Jiang, L. and Cheng, Z. (2018) Increased Serum IL-17 and Decreased Serum IL-10 and IL-35 Levels Correlate with the Progression of COPD. International Journal of Chronic Obstructive Pulmonary Disease, 13, 2483-2494. https://doi.org/10.2147/copd.s167192
|